Up a level |
Jump to: Journal Article | Thesis
Number of items: 2.
Journal Article
Muinos-Buehl, A., Rombo, R., Janzen, E., Ling, K. K., Hupperich, K., Rigo, F., Bennett, C. F. and Wirth, B. (2022). Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks. Neurobiol. Dis., 171. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1095-953X
Thesis
Muinos-Buehl, A. (2023). Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA). PhD thesis, Universität zu Köln.